Peter S. Garcia

Peter S. Garcia (finance chief) discloses dealings in 3 companies, chiefly ALX Oncology Holdings Inc, Durect Corp and PDL Biopharma, Inc. Between 26 January 2016 and 11 September 2025, the trades on record add up to 18 filings.

Both buying and selling appear: 2 purchases worth €191k, against 3 sales worth €41k. The net balance comes to €150k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants and 6 option exercises.

The latest filing, published on 12 September 2025, reports a transaction in Durect Corp. The clock since the last published purchase (24 June 2024) now reads 846 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.